0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Paclitaxel and Docetaxel APIs Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-8Q17730
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Paclitaxel and Docetaxel APIs Market Research Report 2024
BUY CHAPTERS

Global Paclitaxel and Docetaxel APIs Market Research Report 2024

Code: QYRE-Auto-8Q17730
Report
June 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Paclitaxel and Docetaxel APIs Market

Paclitaxel is a chemotherapy medication used to treat ovarian cancer, esophageal cancer, breast cancer, lung cancer, Kaposi's sarcoma, cervical cancer, and pancreatic cancer. It is administered by intravenous injection. There is also an albumin-bound formulation.
Docetaxel (DTX or DXL) is a chemotherapy medication used to treat a number of types of cancer. This includes breast cancer, head and neck cancer, stomach cancer, prostAate cancer and non-small-cell lung cancer.
The global Paclitaxel and Docetaxel APIs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Paclitaxel and Docetaxel APIs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Paclitaxel and Docetaxel APIs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Paclitaxel and Docetaxel APIs include Phyton Biotech, ScinoPharm, Samyang Biopharm, Indena, Teva API, Guilin Huiang Biochemical Pharmaceutical, Yunnan Hande, Taxus Pharma, Fujian South Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Paclitaxel and Docetaxel APIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel and Docetaxel APIs.
The Paclitaxel and Docetaxel APIs market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Paclitaxel and Docetaxel APIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paclitaxel and Docetaxel APIs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Paclitaxel and Docetaxel APIs Market Report

Report Metric Details
Report Name Paclitaxel and Docetaxel APIs Market
Segment by Type
  • Paclitaxel API
  • Docetaxel API
Segment by Application
  • Paclitaxel Injection
  • Paclitaxel Liposomes
  • Nab-paclitaxel
  • Docetaxel Injection
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Phyton Biotech, ScinoPharm, Samyang Biopharm, Indena, Teva API, Guilin Huiang Biochemical Pharmaceutical, Yunnan Hande, Taxus Pharma, Fujian South Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Paclitaxel and Docetaxel APIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Paclitaxel and Docetaxel APIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Paclitaxel and Docetaxel APIs Market report?

Ans: The main players in the Paclitaxel and Docetaxel APIs Market are Phyton Biotech, ScinoPharm, Samyang Biopharm, Indena, Teva API, Guilin Huiang Biochemical Pharmaceutical, Yunnan Hande, Taxus Pharma, Fujian South Pharmaceutical

What are the Application segmentation covered in the Paclitaxel and Docetaxel APIs Market report?

Ans: The Applications covered in the Paclitaxel and Docetaxel APIs Market report are Paclitaxel Injection, Paclitaxel Liposomes, Nab-paclitaxel, Docetaxel Injection

What are the Type segmentation covered in the Paclitaxel and Docetaxel APIs Market report?

Ans: The Types covered in the Paclitaxel and Docetaxel APIs Market report are Paclitaxel API, Docetaxel API

1 Paclitaxel and Docetaxel APIs Market Overview
1.1 Product Definition
1.2 Paclitaxel and Docetaxel APIs by Type
1.2.1 Global Paclitaxel and Docetaxel APIs Market Value Comparison by Type (2024-2030)
1.2.2 Paclitaxel API
1.2.3 Docetaxel API
1.3 Paclitaxel and Docetaxel APIs by Application
1.3.1 Global Paclitaxel and Docetaxel APIs Market Value by Application (2024-2030)
1.3.2 Paclitaxel Injection
1.3.3 Paclitaxel Liposomes
1.3.4 Nab-paclitaxel
1.3.5 Docetaxel Injection
1.4 Global Paclitaxel and Docetaxel APIs Market Size Estimates and Forecasts
1.4.1 Global Paclitaxel and Docetaxel APIs Revenue 2019-2030
1.4.2 Global Paclitaxel and Docetaxel APIs Sales 2019-2030
1.4.3 Global Paclitaxel and Docetaxel APIs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Paclitaxel and Docetaxel APIs Market Competition by Manufacturers
2.1 Global Paclitaxel and Docetaxel APIs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Paclitaxel and Docetaxel APIs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Paclitaxel and Docetaxel APIs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Paclitaxel and Docetaxel APIs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Paclitaxel and Docetaxel APIs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Paclitaxel and Docetaxel APIs, Product Type & Application
2.7 Global Key Manufacturers of Paclitaxel and Docetaxel APIs, Date of Enter into This Industry
2.8 Global Paclitaxel and Docetaxel APIs Market Competitive Situation and Trends
2.8.1 Global Paclitaxel and Docetaxel APIs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Paclitaxel and Docetaxel APIs Players Market Share by Revenue
2.8.3 Global Paclitaxel and Docetaxel APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Paclitaxel and Docetaxel APIs Market Scenario by Region
3.1 Global Paclitaxel and Docetaxel APIs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Paclitaxel and Docetaxel APIs Sales by Region: 2019-2030
3.2.1 Global Paclitaxel and Docetaxel APIs Sales by Region: 2019-2024
3.2.2 Global Paclitaxel and Docetaxel APIs Sales by Region: 2025-2030
3.3 Global Paclitaxel and Docetaxel APIs Revenue by Region: 2019-2030
3.3.1 Global Paclitaxel and Docetaxel APIs Revenue by Region: 2019-2024
3.3.2 Global Paclitaxel and Docetaxel APIs Revenue by Region: 2025-2030
3.4 North America Paclitaxel and Docetaxel APIs Market Facts & Figures by Country
3.4.1 North America Paclitaxel and Docetaxel APIs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Paclitaxel and Docetaxel APIs Sales by Country (2019-2030)
3.4.3 North America Paclitaxel and Docetaxel APIs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Paclitaxel and Docetaxel APIs Market Facts & Figures by Country
3.5.1 Europe Paclitaxel and Docetaxel APIs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Paclitaxel and Docetaxel APIs Sales by Country (2019-2030)
3.5.3 Europe Paclitaxel and Docetaxel APIs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Paclitaxel and Docetaxel APIs Market Facts & Figures by Region
3.6.1 Asia Pacific Paclitaxel and Docetaxel APIs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Paclitaxel and Docetaxel APIs Sales by Region (2019-2030)
3.6.3 Asia Pacific Paclitaxel and Docetaxel APIs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Paclitaxel and Docetaxel APIs Market Facts & Figures by Country
3.7.1 Latin America Paclitaxel and Docetaxel APIs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Paclitaxel and Docetaxel APIs Sales by Country (2019-2030)
3.7.3 Latin America Paclitaxel and Docetaxel APIs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Paclitaxel and Docetaxel APIs Market Facts & Figures by Country
3.8.1 Middle East and Africa Paclitaxel and Docetaxel APIs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Paclitaxel and Docetaxel APIs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Paclitaxel and Docetaxel APIs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Paclitaxel and Docetaxel APIs Sales by Type (2019-2030)
4.1.1 Global Paclitaxel and Docetaxel APIs Sales by Type (2019-2024)
4.1.2 Global Paclitaxel and Docetaxel APIs Sales by Type (2025-2030)
4.1.3 Global Paclitaxel and Docetaxel APIs Sales Market Share by Type (2019-2030)
4.2 Global Paclitaxel and Docetaxel APIs Revenue by Type (2019-2030)
4.2.1 Global Paclitaxel and Docetaxel APIs Revenue by Type (2019-2024)
4.2.2 Global Paclitaxel and Docetaxel APIs Revenue by Type (2025-2030)
4.2.3 Global Paclitaxel and Docetaxel APIs Revenue Market Share by Type (2019-2030)
4.3 Global Paclitaxel and Docetaxel APIs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Paclitaxel and Docetaxel APIs Sales by Application (2019-2030)
5.1.1 Global Paclitaxel and Docetaxel APIs Sales by Application (2019-2024)
5.1.2 Global Paclitaxel and Docetaxel APIs Sales by Application (2025-2030)
5.1.3 Global Paclitaxel and Docetaxel APIs Sales Market Share by Application (2019-2030)
5.2 Global Paclitaxel and Docetaxel APIs Revenue by Application (2019-2030)
5.2.1 Global Paclitaxel and Docetaxel APIs Revenue by Application (2019-2024)
5.2.2 Global Paclitaxel and Docetaxel APIs Revenue by Application (2025-2030)
5.2.3 Global Paclitaxel and Docetaxel APIs Revenue Market Share by Application (2019-2030)
5.3 Global Paclitaxel and Docetaxel APIs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Phyton Biotech
6.1.1 Phyton Biotech Company Information
6.1.2 Phyton Biotech Description and Business Overview
6.1.3 Phyton Biotech Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Phyton Biotech Paclitaxel and Docetaxel APIs Product Portfolio
6.1.5 Phyton Biotech Recent Developments/Updates
6.2 ScinoPharm
6.2.1 ScinoPharm Company Information
6.2.2 ScinoPharm Description and Business Overview
6.2.3 ScinoPharm Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ScinoPharm Paclitaxel and Docetaxel APIs Product Portfolio
6.2.5 ScinoPharm Recent Developments/Updates
6.3 Samyang Biopharm
6.3.1 Samyang Biopharm Company Information
6.3.2 Samyang Biopharm Description and Business Overview
6.3.3 Samyang Biopharm Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Samyang Biopharm Paclitaxel and Docetaxel APIs Product Portfolio
6.3.5 Samyang Biopharm Recent Developments/Updates
6.4 Indena
6.4.1 Indena Company Information
6.4.2 Indena Description and Business Overview
6.4.3 Indena Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Indena Paclitaxel and Docetaxel APIs Product Portfolio
6.4.5 Indena Recent Developments/Updates
6.5 Teva API
6.5.1 Teva API Company Information
6.5.2 Teva API Description and Business Overview
6.5.3 Teva API Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva API Paclitaxel and Docetaxel APIs Product Portfolio
6.5.5 Teva API Recent Developments/Updates
6.6 Guilin Huiang Biochemical Pharmaceutical
6.6.1 Guilin Huiang Biochemical Pharmaceutical Company Information
6.6.2 Guilin Huiang Biochemical Pharmaceutical Description and Business Overview
6.6.3 Guilin Huiang Biochemical Pharmaceutical Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Guilin Huiang Biochemical Pharmaceutical Paclitaxel and Docetaxel APIs Product Portfolio
6.6.5 Guilin Huiang Biochemical Pharmaceutical Recent Developments/Updates
6.7 Yunnan Hande
6.7.1 Yunnan Hande Company Information
6.7.2 Yunnan Hande Description and Business Overview
6.7.3 Yunnan Hande Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Yunnan Hande Paclitaxel and Docetaxel APIs Product Portfolio
6.7.5 Yunnan Hande Recent Developments/Updates
6.8 Taxus Pharma
6.8.1 Taxus Pharma Company Information
6.8.2 Taxus Pharma Description and Business Overview
6.8.3 Taxus Pharma Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Taxus Pharma Paclitaxel and Docetaxel APIs Product Portfolio
6.8.5 Taxus Pharma Recent Developments/Updates
6.9 Fujian South Pharmaceutical
6.9.1 Fujian South Pharmaceutical Company Information
6.9.2 Fujian South Pharmaceutical Description and Business Overview
6.9.3 Fujian South Pharmaceutical Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Fujian South Pharmaceutical Paclitaxel and Docetaxel APIs Product Portfolio
6.9.5 Fujian South Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Paclitaxel and Docetaxel APIs Industry Chain Analysis
7.2 Paclitaxel and Docetaxel APIs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Paclitaxel and Docetaxel APIs Production Mode & Process
7.4 Paclitaxel and Docetaxel APIs Sales and Marketing
7.4.1 Paclitaxel and Docetaxel APIs Sales Channels
7.4.2 Paclitaxel and Docetaxel APIs Distributors
7.5 Paclitaxel and Docetaxel APIs Customers
8 Paclitaxel and Docetaxel APIs Market Dynamics
8.1 Paclitaxel and Docetaxel APIs Industry Trends
8.2 Paclitaxel and Docetaxel APIs Market Drivers
8.3 Paclitaxel and Docetaxel APIs Market Challenges
8.4 Paclitaxel and Docetaxel APIs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Paclitaxel and Docetaxel APIs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Paclitaxel and Docetaxel APIs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Paclitaxel and Docetaxel APIs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Paclitaxel and Docetaxel APIs Sales (Kg) of Key Manufacturers (2019-2024)
 Table 5. Global Paclitaxel and Docetaxel APIs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Paclitaxel and Docetaxel APIs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Paclitaxel and Docetaxel APIs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Paclitaxel and Docetaxel APIs Average Price (US$/Kg) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Paclitaxel and Docetaxel APIs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Paclitaxel and Docetaxel APIs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Paclitaxel and Docetaxel APIs, Product Type & Application
 Table 12. Global Key Manufacturers of Paclitaxel and Docetaxel APIs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Paclitaxel and Docetaxel APIs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel and Docetaxel APIs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Paclitaxel and Docetaxel APIs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Paclitaxel and Docetaxel APIs Sales by Region (2019-2024) & (Kg)
 Table 18. Global Paclitaxel and Docetaxel APIs Sales Market Share by Region (2019-2024)
 Table 19. Global Paclitaxel and Docetaxel APIs Sales by Region (2025-2030) & (Kg)
 Table 20. Global Paclitaxel and Docetaxel APIs Sales Market Share by Region (2025-2030)
 Table 21. Global Paclitaxel and Docetaxel APIs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Paclitaxel and Docetaxel APIs Revenue Market Share by Region (2019-2024)
 Table 23. Global Paclitaxel and Docetaxel APIs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Paclitaxel and Docetaxel APIs Revenue Market Share by Region (2025-2030)
 Table 25. North America Paclitaxel and Docetaxel APIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Paclitaxel and Docetaxel APIs Sales by Country (2019-2024) & (Kg)
 Table 27. North America Paclitaxel and Docetaxel APIs Sales by Country (2025-2030) & (Kg)
 Table 28. North America Paclitaxel and Docetaxel APIs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Paclitaxel and Docetaxel APIs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Paclitaxel and Docetaxel APIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Paclitaxel and Docetaxel APIs Sales by Country (2019-2024) & (Kg)
 Table 32. Europe Paclitaxel and Docetaxel APIs Sales by Country (2025-2030) & (Kg)
 Table 33. Europe Paclitaxel and Docetaxel APIs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Paclitaxel and Docetaxel APIs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Paclitaxel and Docetaxel APIs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Paclitaxel and Docetaxel APIs Sales by Region (2019-2024) & (Kg)
 Table 37. Asia Pacific Paclitaxel and Docetaxel APIs Sales by Region (2025-2030) & (Kg)
 Table 38. Asia Pacific Paclitaxel and Docetaxel APIs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Paclitaxel and Docetaxel APIs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Paclitaxel and Docetaxel APIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Paclitaxel and Docetaxel APIs Sales by Country (2019-2024) & (Kg)
 Table 42. Latin America Paclitaxel and Docetaxel APIs Sales by Country (2025-2030) & (Kg)
 Table 43. Latin America Paclitaxel and Docetaxel APIs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Paclitaxel and Docetaxel APIs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Paclitaxel and Docetaxel APIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Paclitaxel and Docetaxel APIs Sales by Country (2019-2024) & (Kg)
 Table 47. Middle East and Africa Paclitaxel and Docetaxel APIs Sales by Country (2025-2030) & (Kg)
 Table 48. Middle East and Africa Paclitaxel and Docetaxel APIs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Paclitaxel and Docetaxel APIs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Paclitaxel and Docetaxel APIs Sales (Kg) by Type (2019-2024)
 Table 51. Global Paclitaxel and Docetaxel APIs Sales (Kg) by Type (2025-2030)
 Table 52. Global Paclitaxel and Docetaxel APIs Sales Market Share by Type (2019-2024)
 Table 53. Global Paclitaxel and Docetaxel APIs Sales Market Share by Type (2025-2030)
 Table 54. Global Paclitaxel and Docetaxel APIs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Paclitaxel and Docetaxel APIs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Paclitaxel and Docetaxel APIs Revenue Market Share by Type (2019-2024)
 Table 57. Global Paclitaxel and Docetaxel APIs Revenue Market Share by Type (2025-2030)
 Table 58. Global Paclitaxel and Docetaxel APIs Price (US$/Kg) by Type (2019-2024)
 Table 59. Global Paclitaxel and Docetaxel APIs Price (US$/Kg) by Type (2025-2030)
 Table 60. Global Paclitaxel and Docetaxel APIs Sales (Kg) by Application (2019-2024)
 Table 61. Global Paclitaxel and Docetaxel APIs Sales (Kg) by Application (2025-2030)
 Table 62. Global Paclitaxel and Docetaxel APIs Sales Market Share by Application (2019-2024)
 Table 63. Global Paclitaxel and Docetaxel APIs Sales Market Share by Application (2025-2030)
 Table 64. Global Paclitaxel and Docetaxel APIs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Paclitaxel and Docetaxel APIs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Paclitaxel and Docetaxel APIs Revenue Market Share by Application (2019-2024)
 Table 67. Global Paclitaxel and Docetaxel APIs Revenue Market Share by Application (2025-2030)
 Table 68. Global Paclitaxel and Docetaxel APIs Price (US$/Kg) by Application (2019-2024)
 Table 69. Global Paclitaxel and Docetaxel APIs Price (US$/Kg) by Application (2025-2030)
 Table 70. Phyton Biotech Company Information
 Table 71. Phyton Biotech Description and Business Overview
 Table 72. Phyton Biotech Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 73. Phyton Biotech Paclitaxel and Docetaxel APIs Product
 Table 74. Phyton Biotech Recent Developments/Updates
 Table 75. ScinoPharm Company Information
 Table 76. ScinoPharm Description and Business Overview
 Table 77. ScinoPharm Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 78. ScinoPharm Paclitaxel and Docetaxel APIs Product
 Table 79. ScinoPharm Recent Developments/Updates
 Table 80. Samyang Biopharm Company Information
 Table 81. Samyang Biopharm Description and Business Overview
 Table 82. Samyang Biopharm Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 83. Samyang Biopharm Paclitaxel and Docetaxel APIs Product
 Table 84. Samyang Biopharm Recent Developments/Updates
 Table 85. Indena Company Information
 Table 86. Indena Description and Business Overview
 Table 87. Indena Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 88. Indena Paclitaxel and Docetaxel APIs Product
 Table 89. Indena Recent Developments/Updates
 Table 90. Teva API Company Information
 Table 91. Teva API Description and Business Overview
 Table 92. Teva API Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 93. Teva API Paclitaxel and Docetaxel APIs Product
 Table 94. Teva API Recent Developments/Updates
 Table 95. Guilin Huiang Biochemical Pharmaceutical Company Information
 Table 96. Guilin Huiang Biochemical Pharmaceutical Description and Business Overview
 Table 97. Guilin Huiang Biochemical Pharmaceutical Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 98. Guilin Huiang Biochemical Pharmaceutical Paclitaxel and Docetaxel APIs Product
 Table 99. Guilin Huiang Biochemical Pharmaceutical Recent Developments/Updates
 Table 100. Yunnan Hande Company Information
 Table 101. Yunnan Hande Description and Business Overview
 Table 102. Yunnan Hande Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 103. Yunnan Hande Paclitaxel and Docetaxel APIs Product
 Table 104. Yunnan Hande Recent Developments/Updates
 Table 105. Taxus Pharma Company Information
 Table 106. Taxus Pharma Description and Business Overview
 Table 107. Taxus Pharma Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 108. Taxus Pharma Paclitaxel and Docetaxel APIs Product
 Table 109. Taxus Pharma Recent Developments/Updates
 Table 110. Fujian South Pharmaceutical Company Information
 Table 111. Fujian South Pharmaceutical Description and Business Overview
 Table 112. Fujian South Pharmaceutical Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 113. Fujian South Pharmaceutical Paclitaxel and Docetaxel APIs Product
 Table 114. Fujian South Pharmaceutical Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Paclitaxel and Docetaxel APIs Distributors List
 Table 118. Paclitaxel and Docetaxel APIs Customers List
 Table 119. Paclitaxel and Docetaxel APIs Market Trends
 Table 120. Paclitaxel and Docetaxel APIs Market Drivers
 Table 121. Paclitaxel and Docetaxel APIs Market Challenges
 Table 122. Paclitaxel and Docetaxel APIs Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Paclitaxel and Docetaxel APIs
 Figure 2. Global Paclitaxel and Docetaxel APIs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Paclitaxel and Docetaxel APIs Market Share by Type: 2023 & 2030
 Figure 4. Paclitaxel API Product Picture
 Figure 5. Docetaxel API Product Picture
 Figure 6. Global Paclitaxel and Docetaxel APIs Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Paclitaxel and Docetaxel APIs Market Share by Application: 2023 & 2030
 Figure 8. Paclitaxel Injection
 Figure 9. Paclitaxel Liposomes
 Figure 10. Nab-paclitaxel
 Figure 11. Docetaxel Injection
 Figure 12. Global Paclitaxel and Docetaxel APIs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Paclitaxel and Docetaxel APIs Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Paclitaxel and Docetaxel APIs Sales (2019-2030) & (Kg)
 Figure 15. Global Paclitaxel and Docetaxel APIs Average Price (US$/Kg) & (2019-2030)
 Figure 16. Paclitaxel and Docetaxel APIs Report Years Considered
 Figure 17. Paclitaxel and Docetaxel APIs Sales Share by Manufacturers in 2023
 Figure 18. Global Paclitaxel and Docetaxel APIs Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Paclitaxel and Docetaxel APIs Players: Market Share by Revenue in Paclitaxel and Docetaxel APIs in 2023
 Figure 20. Paclitaxel and Docetaxel APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Paclitaxel and Docetaxel APIs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Paclitaxel and Docetaxel APIs Sales Market Share by Country (2019-2030)
 Figure 23. North America Paclitaxel and Docetaxel APIs Revenue Market Share by Country (2019-2030)
 Figure 24. United States Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Paclitaxel and Docetaxel APIs Sales Market Share by Country (2019-2030)
 Figure 27. Europe Paclitaxel and Docetaxel APIs Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Paclitaxel and Docetaxel APIs Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Paclitaxel and Docetaxel APIs Revenue Market Share by Region (2019-2030)
 Figure 35. China Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Paclitaxel and Docetaxel APIs Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Paclitaxel and Docetaxel APIs Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Paclitaxel and Docetaxel APIs Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Paclitaxel and Docetaxel APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Paclitaxel and Docetaxel APIs by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Paclitaxel and Docetaxel APIs by Type (2019-2030)
 Figure 54. Global Paclitaxel and Docetaxel APIs Price (US$/Kg) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Paclitaxel and Docetaxel APIs by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Paclitaxel and Docetaxel APIs by Application (2019-2030)
 Figure 57. Global Paclitaxel and Docetaxel APIs Price (US$/Kg) by Application (2019-2030)
 Figure 58. Paclitaxel and Docetaxel APIs Value Chain
 Figure 59. Paclitaxel and Docetaxel APIs Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India